Patents by Inventor Torsten Trowe

Torsten Trowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150297605
    Abstract: Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount a second active agent to a patient having a cancer.
    Type: Application
    Filed: April 15, 2015
    Publication date: October 22, 2015
    Inventor: Torsten TROWE
  • Patent number: 8105785
    Abstract: Human MYLK genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MYLK are provided.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: January 31, 2012
    Assignee: Exelixis, Inc.
    Inventors: Gregory D. Plowman, Felix D. Karim, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek, Stefan Schulte-Merker, Ulrike Eisenmann, Gordon Mark Stott, Torsten Trowe, Andreas Michael Vogel, Joerg Heinrich Odenthal, Jochen Konrad Scheel, Torsten Tilmann Will, Yinsheng Jin, Lynn Margaret Bjerke, Timothy S. Heuer
  • Publication number: 20080317738
    Abstract: Human MYLK genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MYLK are provided.
    Type: Application
    Filed: June 18, 2004
    Publication date: December 25, 2008
    Applicant: Exelixis, Inc.
    Inventors: Gregory D. Plowman, Felix D. Karim, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek, Stefan Schulte-Merker, Ulrike Eisenmann, Gordon Mark Stott, Torsten Trowe, Andreas Michael Vogel, Joerg Heinrich Odenthal, Jochen Konrad Scheel, Torsten Tilmann Will, Yinsheng Jin, Lynn Margaret Bjerke, Timothy S. Heuer
  • Publication number: 20080213247
    Abstract: Human MBM genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MBM are provided.
    Type: Application
    Filed: October 22, 2003
    Publication date: September 4, 2008
    Inventors: Gregory D. Plowman, Felix D. Karim, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek, Stefan Schulte-Merker, Ulrike Langheinrich, Gordon Mark Stott, Torsten Trowe, Andreas Michael Vogel, Joerg Heinrich Odenthal, Jochen Konrad Scheel, Torsten Tilmann Will, Yisheng Jin, Lynn Margaret Bjerke, Bing Hai, Joanne I. Adamkewicz, Kim Licketeig, R. Glenn R. Hammonds, Craig D. Amundsen, Haiguang Zhang, Monique Nicoll
  • Publication number: 20070269378
    Abstract: Human NADK genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morpho-genesis, comprising screening for agents that modulate the activity of NADK are provided.
    Type: Application
    Filed: June 18, 2004
    Publication date: November 22, 2007
    Applicant: EXELIXIS INC.
    Inventors: Gregory Plowman, Felix Karim, Candace Swimmer, Hinrich Habeck, Thomas Koblizek, Stefan Schulte-Merker, Ulrike Eisenmann, Gordon Stott, Torsten Trowe, Andreas Vogel, Joerg Odenthal, Jochen Scheel, Torsten Will, Yinsheng Jin, Lynn Bjerke, Timothy Heuer
  • Publication number: 20070003927
    Abstract: Human MAPK7 genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MAPK7 are provided.
    Type: Application
    Filed: October 22, 2003
    Publication date: January 4, 2007
    Inventors: Gregory Plowman, Felix Karim, Candace Swimmer, Hinrich Habeck, Thomas Koblizek, Stefan Schulte-Merker, Ulrike Langheinrich, Gordon Stott, Torsten Trowe, Andreas Vogel, Joerg Heinrich, Jochen Scheel, Torsten Will, Yisheng Jin, Joanne Adamkewicz
  • Publication number: 20060257870
    Abstract: Human CDKL1 genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of CDKL1 are provided.
    Type: Application
    Filed: October 22, 2003
    Publication date: November 16, 2006
    Inventors: Gregory Plowman, Felix Karim, Candace Swimmer, Hinrich Habeck, Thomas Koblizek, Stefan Schulte-Merker, Ulrike Langheinrich, Gordon Stott, Torsten Trowe, Andreas Vogel, Joerg Odenthal, Jochen Scheel, Torsten Will, Yisheng Jin, Bing Hai